Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women

K. A. Kissell, M. R. Danaher, E. F. Schisterman, J. Wactawski-Wende, K. A. Ahrens, K. Schliep, N. J. Perkins, L. Sjaarda, J. Weck, S. L. Mumford

Research output: Contribution to journalArticle

Abstract

Study Question: Does serum anti-Müllerian hormone (AMH) vary significantly throughout both ovulatory and sporadic anovulatory menstrual cycles in healthy premenopausal women? summaryanswer: Serum AMH levels vary statistically significantly across the menstrual cycle in both ovulatory and sporadic anovulatory cycles of healthy eumenorrheic women. what is known already: Studies to date evaluating serum AMH levels throughout the menstrual cycle have conflicting results regarding intra-woman cyclicity. No previous studies have evaluated an association between AMH and sporadic anovulation. study design, size, duration:We conducted a prospective cohort study of 259 regularly menstruating women recruited between 2005 and 2007. participants/materials, setting, methods: Women aged 18-44 years were followed for one (n = 9) or two (n = 250) menstrual cycles. Anovulatory cycles were defined as any cycle with peak progesterone concentration ≤5 ng/ml and no serum LH peak on the mid or late luteal visits. Serum AMH was measured at up to eight-time points throughout each cycle. main results and the role of chance: Geometric mean AMH levels were observed to vary across the menstrual cycle (P <0.01) with the highest levels observed during the mid-follicular phase at 2.06 ng/ml, decreasing around the time of ovulation to 1.79 ng/ml and increasing thereafter to 1.93 (mid-follicular versus ovulation, P <0.01; ovulation versus late luteal, P = 0.01; mid-follicular versus late luteal, P = 0.05). Patterns were similar across all age groups and during ovulatory and anovulatory cycles, with higher levels ofAMHobserved among women with one or more anovulatory cycles (P = 0.03). limitations, reasons for caution: Ovulatory statuswas not verified by direct visualization.AMHwas analyzed using the original Generation II enzymatically amplified two-site immunoassay, which has been shown to be susceptible to assay interference. Thus, absolute levels should be interpreted with caution, however, patterns and associations remain consistent and any potential bias would be non-differential. wider implications of the findings: This study demonstrates a significant variation in serum AMH levels across the menstrual cycle regardless of ovulatory status. This variability, although statistically significant, is not large enough towarrant a change in current clinical practice to time AMH measurements to cycle day/phase.

Original languageEnglish (US)
Pages (from-to)1764-1772
Number of pages9
JournalHuman Reproduction
Volume29
Issue number8
DOIs
StatePublished - 2014
Externally publishedYes

Keywords

  • Anovulation
  • Anti-Müllerian hormone
  • Menstrual cycle

ASJC Scopus subject areas

  • Rehabilitation
  • Obstetrics and Gynecology
  • Reproductive Medicine
  • Medicine(all)

Fingerprint Dive into the research topics of 'Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women'. Together they form a unique fingerprint.

  • Cite this

    Kissell, K. A., Danaher, M. R., Schisterman, E. F., Wactawski-Wende, J., Ahrens, K. A., Schliep, K., Perkins, N. J., Sjaarda, L., Weck, J., & Mumford, S. L. (2014). Biological variability in serum anti-Müllerian hormone throughout the menstrual cycle in ovulatory and sporadic anovulatory cycles in eumenorrheic women. Human Reproduction, 29(8), 1764-1772. https://doi.org/10.1093/humrep/deu142